The U.S. Senate confirmed Dr. Rahul Gupta as Director of the White House Office of National Drug Control Policy, making him the first physician to lead the nation’s drug policy office. His appointment marked a significant shift in federal strategy, placing a clinician at the center of efforts to address the opioid and fentanyl epidemics. Under Gupta’s leadership, the office emphasized prevention, treatment, recovery, and harm reduction alongside law enforcement. The appointment reflected a broader transition toward viewing substance use disorder as a public health challenge requiring medical as well as policy solutions.
